mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
-0.036 |
0.8 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.8 |